GUGGENHEIM CAPITAL LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$810,879
-1.4%
9,052
-13.5%
0.01%0.0%
Q4 2022$822,600
-8.0%
10,459
-13.4%
0.01%
-12.5%
Q3 2022$894,000
+12.5%
12,078
-1.1%
0.01%
+33.3%
Q2 2022$795,000
-2.3%
12,210
-5.1%
0.01%
+20.0%
Q1 2022$814,000
+24.3%
12,867
+4.3%
0.01%
+66.7%
Q4 2021$655,000
-32.8%
12,342
-10.5%
0.00%
-50.0%
Q3 2021$974,000
+30.0%
13,797
+22.7%
0.01%
+50.0%
Q2 2021$749,000
-27.8%
11,243
+20.3%
0.00%
-42.9%
Q1 2021$1,038,000
+138.1%
9,349
+154.5%
0.01%
+133.3%
Q4 2020$436,000
+85.5%
3,674
+55.7%
0.00%
+50.0%
Q1 2020$235,000
-36.7%
2,359
-27.0%
0.00%
-33.3%
Q4 2019$371,000
-48.3%
3,231
-43.2%
0.00%
-50.0%
Q3 2019$717,000
+33.8%
5,687
+27.6%
0.01%
+50.0%
Q2 2019$536,000
+25.5%
4,458
-8.7%
0.00%
+33.3%
Q1 2019$427,000
-23.3%
4,882
-12.2%
0.00%
-40.0%
Q4 2018$557,000
+167.8%
5,563
-6.3%
0.01%
Q3 2014$208,000
+3.0%
5,938
+3.3%
0.00%
-100.0%
Q2 2014$202,0000.0%5,747
-6.9%
0.00%0.0%
Q1 2014$202,000
-35.3%
6,173
-21.0%
0.00%0.0%
Q3 2013$312,000
-4.0%
7,813
-0.6%
0.00%0.0%
Q2 2013$325,0007,8610.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders